Technical Analysis for JNJ - Johnson & Johnson

Grade Last Price % Change Price Change
A 171.79 1.06% 1.81
JNJ closed up 1.06 percent on Friday, July 23, 2021, on 79 percent of normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Up Up
Historical JNJ trend table...

Date Alert Name Type % Chg
New 52 Week Closing High Bullish 0.00%
Stochastic Reached Overbought Strength 0.00%
Overbought Stochastic Strength 0.00%
Up 3 Days in a Row Strength 0.00%
Up 4 Days in a Row Strength 0.00%
Multiple of Ten Bearish Other 1.06%
Up 3 Days in a Row Strength 1.06%
Cup with Handle Other 1.36%
Inside Day Range Contraction 1.36%
20 DMA Support Bullish 1.98%
Older End-of-Day Signals for JNJ ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Johnson & Johnson Description

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of various products in the health care field worldwide. The company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics. The Consumer segment offers products used in the baby care, skin care, oral care, wound care, and women's health fields, as well as nutritional and over-the-counter pharmaceutical products, and wellness and prevention platforms under the JOHNSON'S, AVEENO, CLEAN & CLEAR, NEUTROGENA, RoC, LUBRIDERM, DABAO, VENDÔME, LISTERINE, REMBRANDT, REACH, BAND-AID, NEOSPORIN, CAREFREE, STAYFREE, SPLENDA, TYLENOL, SUDAFED, ZYRTEC, MOTRIN IB, and PEPCID AC brand names. This segment markets its products to the general public, as well as to retail outlets and distributors. The Pharmaceutical segment provides various products in the areas of anti-infective, antipsychotic, contraceptive, gastrointestinal, hematology, immunology, infectious diseases, neurology, oncology, pain management, thrombosis, and vaccines. This segment distributes its products directly to retailers, wholesalers, and health care professionals for prescription use. The Medical Devices and Diagnostics segment offers products to treat cardiovascular disease; orthopaedic and neurological products; blood glucose monitoring and insulin delivery products; general surgery, biosurgical, and energy products; professional diagnostic products; infection prevention products; and disposable contact lenses. This segment distributes its products directly, as well as through surgical supply and other distributors to wholesalers, hospitals, and retailers. Johnson & Johnson was founded in 1886 and is based in New Brunswick, New Jersey.


Sector: Healthcare
Industry: Drug Manufacturers - Major
Keywords: S&P 500 Immunology Pain Infectious Diseases Pharmaceutical Products Gastrointestinal Retail Outlets Pharmacology Dow Jones Component Healthcare Industry Infection Hematology Skin Care Urology Cardiovascular Disease Wound Pain Management Glucose Insulin Diagnostic Products Neurology Energy Products Lenses Infection Prevention Blood Glucose Monitoring EPC Contact Lens General Surgery Contact Lenses Thrombosis Antipsychotic Neos Epci Infection Prevention Products Counter Pharmaceutical Products Insulin Delivery Urological Products

Is JNJ a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 173.65
52 Week Low 133.65
Average Volume 6,223,780
200-Day Moving Average 159.30
50-Day Moving Average 167.32
20-Day Moving Average 168.02
10-Day Moving Average 169.22
Average True Range 2.14
ADX 24.12
+DI 29.70
-DI 15.56
Chandelier Exit (Long, 3 ATRs) 165.74
Chandelier Exit (Short, 3 ATRs) 168.91
Upper Bollinger Bands 172.48
Lower Bollinger Band 163.55
Percent B (%b) 0.92
BandWidth 5.32
MACD Line 1.09
MACD Signal Line 0.83
MACD Histogram 0.256
Fundamentals Value
Market Cap 452.24 Billion
Num Shares 2.63 Billion
EPS 6.36
Price-to-Earnings (P/E) Ratio 27.01
Price-to-Sales 4.92
Price-to-Book 6.08
PEG Ratio 2.77
Dividend 4.04
Dividend Yield 2.35%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 174.47
Resistance 3 (R3) 174.30 173.24 174.03
Resistance 2 (R2) 173.24 172.55 173.32 173.88
Resistance 1 (R1) 172.51 172.13 172.87 172.68 173.73
Pivot Point 171.45 171.45 171.63 171.53 171.45
Support 1 (S1) 170.72 170.76 171.09 170.90 169.85
Support 2 (S2) 169.66 170.34 169.74 169.70
Support 3 (S3) 168.93 169.66 169.55
Support 4 (S4) 169.11